A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure ...

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

The U.S. faces an ongoing HIV epidemic, with women, particularly women of color, bearing a heavy burden. While there have ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success ...

Already, significant harm has been done to inhibit progress combating HIV/AIDS, and the next four years could return us to ...

Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...